The medication from prostatitis :: Consumers survey results of for 2 quarter of 2013

Consumers survey results of for 2 quarter of 2013 in category

Gynecology, urology, nephrology / The medication from prostatitis

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	3	Trianol (Sandoz)	40.00%	5

1.		Простамол Уно (Berlin-Chemie Menarini)	40.00%	5

3.	~	Іхтіол (Nizhpharm)	20.00%	2.50

3.		Афала (Materia Medica – Ukraine)	20.00%	2.50

3.		Вітапрост (Nizhpharm)	20.00%	2.50

3.	2	Простамед (Dr. Gustav Klein)	20.00%	2.50

3.	2	ПростаНорм (ФармВілар)	20.00%	2.50

3.	2	Простатон (Національна гомеопатична спілка)	20.00%	2.50

3.	~	Хомвіо-Простан (Homviora Arzneimittel)	20.00%	2.50

–.		Медный всадник (Талион-А)	0.00%	0

–.		Простаплант (Schwabe)	0.00%	0

–.	3	Простатилен-Біофарма (Біофарма)	0.00%	0

–.		Спеман (Фірма ТК Комфорт)	0.00%	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2013, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.